Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and BTB domain-containing protein 12 (ZBTB12) is a nuclear transcription factor containing a BTB/POZ domain and C2H2 zinc finger motifs. It binds DNA in a sequence-specific manner to negatively regulate transcription via RNA polymerase II, and plays a crucial role in human pluripotent stem cell fate by preventing dedifferentiation and enabling proper differentiation into the three germ layers. ZBTB12 acts as a molecular barrier, repressing primate-specific endogenous retroviruses (notably HERVH) and their associated long non-coding RNAs, such as LINC-ROR and ESRG, to ensure unidirectional cell fate transition. The protein is evolutionarily conserved across vertebrates and predominantly localized in the nucleoplasm. Genetic dysfunction of ZBTB12 skews stem cells toward increased self-renewal at the expense of differentiation, highlighting its role in balancing cellular identity and developmental progression; in disease, it is associated with rare conditions such as malignant ovarian cyst and testicular infarct, and may participate in tumorigenic processes.
Not applicable. No drugs directly target ZBTB12.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain-containing protein 12 (ZBTB12).